Advisor Group Holdings »

Crispr Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.7M 91k 62.60
2023-09-30 $4.7M 104k 45.39
2023-06-30 $5.4M 96k 56.14
2023-03-31 $3.8M 85k 45.23
2022-12-31 $2.8M 69k 40.52
2022-09-30 $3.3M 51k 65.37
2022-06-30 $3.1M 51k 60.83
2022-03-31 $3.2M 52k 62.82
2021-12-31 $3.6M 48k 75.79
2021-09-30 $4.7M 42k 111.94
2021-06-30 $5.7M 35k 162.09
2021-03-31 $3.7M 30k 121.91
2020-12-31 $2.7M 18k 153.24
2020-09-30 $1.8M 22k 83.93
2020-06-30 $1.4M 19k 73.21
2020-03-31 $811k 19k 42.26